5382-16-1 | Piperidin-4-ol

Packsize	Purity	Availability	Price	Discounted Price
5g	98%	in stock	$10.00	$7.00
10g	98%	in stock	$12.00	$8.00
25g	98%	in stock	$14.00	$10.00
100g	98%	in stock	$36.00	$25.00
500g	98%	in stock	$79.00	$56.00
1000g	98%	in stock	$157.00	$110.00

Description

• Catalog Number: AB45042
• Chemical Name: Piperidin-4-ol
• CAS Number: 5382-16-1
• Molecular Formula: C5H11NO
• Molecular Weight: 101.1469
• MDL Number: MFCD00005999
• SMILES: OC1CCNCC1
• NSC Number: 62083

Computed Properties

• Complexity: 50
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 7
• Hydrogen Bond Acceptor Count: 2
• Hydrogen Bond Donor Count: 2
• XLogP3: -0.3

Upstream Synthesis Route

4-Hydroxypiperidine is a valuable compound widely used in chemical synthesis as a versatile building block. With its unique structure, 4-Hydroxypiperidine serves as a key intermediate in the production of various pharmaceuticals, agrochemicals, and specialty chemicals. Its hydroxyl group can participate in a variety of chemical reactions, including acylation, alkylation, and oxidation, making it a crucial component in the synthesis of complex organic molecules. Additionally, 4-Hydroxypiperidine can act as a chiral auxiliary, enabling the asymmetric synthesis of enantiopure compounds. Its utility in organic synthesis makes it an indispensable tool for chemists working in drug discovery, material science, and other fields requiring the preparation of structurally diverse molecules.

Literature

• Synthesis of novel IP agonists via N-aminoethyl cyclic amines prepared by decarboxylative ring-opening reactions.

  Molecules (Basel, Switzerland) 20120131

• 4-(4-Chloro-phen-yl)-4-hy-droxy-piperidinium 2-(2-phenyl-eth-yl)benzoate.

  Acta crystallographica. Section E, Structure reports online 20110701

• A Baeyer-Villiger oxidation specifically catalyzed by human flavin-containing monooxygenase 5.

  Drug metabolism and disposition: the biological fate of chemicals 20110101

• 2-Arylbenzoxazoles as CETP inhibitors: raising HDL-C in cynoCETP transgenic mice.

  Bioorganic & medicinal chemistry letters 20110101

• Investigation of 4-piperidinols as novel H3 antagonists.

  Bioorganic & medicinal chemistry letters 20101101

• Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

  Bioorganic & medicinal chemistry letters 20101101

• 4-(4-Chloro-phen-yl)-4-hy-droxy-piperidinium maleate maleic acid solvate.

  Acta crystallographica. Section E, Structure reports online 20100801

• The spectroscopic (FT-IR, FT-IR gas phase, FT-Raman and UV) and NBO analysis of 4-Hydroxypiperidine by density functional method.

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20100301

• 4-(4-Chloro-phen-yl)-1-[3-(4-fluoro-benzo-yl)prop-yl]-4-hydroxy-piperidin-1-ium 2,4,6-trinitro-phenolate (haloperidol picrate).

  Acta crystallographica. Section E, Structure reports online 20091001

• Novel dimeric aryldiketo containing inhibitors of HIV-1 integrase: effects of the phenyl substituent and the linker orientation.

  Bioorganic & medicinal chemistry 20080815

• Erratum: Poly[μ(2)-chlorido-nona-methyl-μ(3)-nitrato-tritin(IV)]. Corrigendum.

  Acta crystallographica. Section E, Structure reports online 20080701

• CCR5 receptor antagonists: discovery and SAR of novel 4-hydroxypiperidine derivatives.

  Bioorganic & medicinal chemistry letters 20070401

• Organosilicon-containing thiazole derivatives as potential lipoxygenase inhibitors and anti-inflammatory agents.

  Bioinorganic chemistry and applications 20070101

• Improved synthesis and radiolabeling of [11C]MP4A, a suitable ligand for the investigation of the cholinergic system using PET.

  Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 20060201

• Structure function differences in nonpeptide CCR1 antagonists for human and mouse CCR1.

  Journal of immunology (Baltimore, Md. : 1950) 20030215

• The influence of conformational restriction in the C-terminus of growth hormone secretagogues on their potency.

  European journal of medicinal chemistry 20020601

• New mu-opioid receptor agonists with phenoxyacetic acid moiety.

  Chemical & pharmaceutical bulletin 20020201

• Cytotoxic and anticancer properties of some 4-aryl-3-arylcarbonyl-1-ethyl-4-piperidinols and related compounds.

  Die Pharmazie 20010501